Jop Kind appointed professor by special appointment of Single Cell Epigenomics

Date of news: 28 September 2021

Jop Kind has been appointed professor by special appointment of Single Cell Epigenomics at the Radboud Faculty of Science, as of 1 September 2021. This teaching and research remit is part of a collaboration with the KNAW / Hubrecht Institute.

Jop Kind is a group leader at the Hubrecht Institute. His group is interested in elucidating the role of chromatin and nuclear architecture in gene-regulation and DNA-repair. Kind develops and employs a combination of genomics and microscopy methods to study how genes are turned on and off in single cells. With these methods, he studies what the mechanisms are that determine how cells acquire new identities and traits in early embryo development and in cancer.


Kind: ’I am interested to find out what the modes of gene regulation are in different biological settings and performs selective manipulations to identify the main drivers of these processes. With this research, we can cast light on disease origins and harness new methods for the development of more sensitive diagnostic strategies. At Radboud University, basic research and the clinic are very well integrated. With the sensitivity of our methods, we hope that we can help further strengthen this connection by creating the possibility to obtain richer information from limited patient material.’

About Jop Kind

Jop Kind (Zuidelijke IJsselmeerpolders, 1978) studied Biology at the University of Amsterdam. He obtained his PhD in Gene regulation at the European Molecular Biology Laboratory (EMBL) in Heidelberg and continued his work there as a postdoc. After that, he worked as a postdoc at the Netherlands Cancer Institute in Amsterdam. In 2014, he started working as a group leader at the Hubrecht Institute.

In 2015, Kind was awarded the Antoni van Leeuwenhoek Award for his research. In 2016, he was awarded the John Kendrew Young Scientist Award and obtained an ERC Starting Grant. In 2018, he was appointed member of the Oncode institute. Earlier this year, Jop Kind received an ERC Consolidator Grant for his research on Epigenetics and cell identity.

For more information, please contact:

  • Radboud University Science Communication,, 024 361 6000